Artelo Biosciences to Present at the H.C. Wainwright 22nd Annual Global Investment Conference on September 15th
LA JOLLA, Calif., Sept. 11, 2020 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company developing therapeutics that modulate the endocannabinoid system, today announced that it will be presenting at the H.C. Wainwright Annual Global Investment Conference, being held virtually on September 14-16, 2020.
Gregory D. Gorgas, President and Chief Executive Officer of Artelo Biosciences, is scheduled to present on Tuesday, September 15th at 3:30 p.m., Eastern Time. The presentation will be webcast live on the conference event platform, which can be accessed here.
About Artelo Biosciences
Investor Relations Contact:
Connectivity Management: Change is Gonna Come